64 related articles for article (PubMed ID: 33962569)
21. Use of gallium-68 prostate-specific membrane antigen positron-emission tomography for detecting lymph node metastases in primary and recurrent prostate cancer and location of recurrence after radical prostatectomy: an overview of the current literature.
Luiting HB; van Leeuwen PJ; Busstra MB; Brabander T; van der Poel HG; Donswijk ML; Vis AN; Emmett L; Stricker PD; Roobol MJ
BJU Int; 2020 Feb; 125(2):206-214. PubMed ID: 31680398
[TBL] [Abstract][Full Text] [Related]
22. Direct comparison of choline PET/CT and MRI in the diagnosis of lymph node metastases in patients with prostate cancer.
Huang SM; Yin L; Yue JL; Li YF; Yang Y; Lin ZC
Medicine (Baltimore); 2018 Dec; 97(50):e13344. PubMed ID: 30557983
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of positron emission tomography in diagnosis of lateral lymph node metastases in patients with rectal Cancer: a retrospective study.
Yukimoto R; Uemura M; Tsuboyama T; Hata T; Fujino S; Ogino T; Miyoshi N; Takahashi H; Hata T; Yamamoto H; Mizushima T; Kida A; Furuyashiki M; Doki Y; Eguchi H
BMC Cancer; 2021 May; 21(1):520. PubMed ID: 33962569
[TBL] [Abstract][Full Text] [Related]
24. Accuracy of F-18 FDG PET/CT with optimal cut-offs of maximum standardized uptake value according to size for diagnosis of regional lymph node metastasis in patients with rectal cancer.
Bae SU; Won KS; Song BI; Jeong WK; Baek SK; Kim HW
Cancer Imaging; 2018 Sep; 18(1):32. PubMed ID: 30217167
[TBL] [Abstract][Full Text] [Related]
25. Correlations between the sizes of lateral pelvic lymph nodes and metastases in rectal cancer patients treated with preoperative chemoradiotherapy.
Ishihara S; Kawai K; Tanaka T; Hata K; Nozawa H
ANZ J Surg; 2018 Dec; 88(12):1306-1310. PubMed ID: 29974631
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic performance of multidetector row computed tomography for assessment of lymph node metastasis in patients with distal rectal cancer.
Kobayashi H; Kikuchi A; Okazaki S; Ishiguro M; Ishikawa T; Iida S; Uetake H; Sugihara K
Ann Surg Oncol; 2015 Jan; 22(1):203-8. PubMed ID: 25124470
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of PET/CT in diagnosis of regional lymph node metastases in patients with colorectal cancer: retrospective cohort study.
Yukimoto R; Uemura M; Tsuboyama T; Sekido Y; Hata T; Ogino T; Miyoshi N; Takahashi H; Kida A; Furuyashiki M; Doki Y; Eguchi H
BJS Open; 2022 Jul; 6(4):. PubMed ID: 35950556
[TBL] [Abstract][Full Text] [Related]
28. Is
Dahmarde H; Parooie F; Salarzaei M
Contrast Media Mol Imaging; 2020; 2020():5439378. PubMed ID: 32733174
[TBL] [Abstract][Full Text] [Related]
29. Pre-operative Evaluation of Lateral Pelvic Lymph Node Metastasis in Lower Rectal Cancer: Comparison of Three Different Imaging Modalities.
Amano K; Fukuchi M; Kumamoto K; Hatano S; Ohno H; Osada H; Ishibashi K; Ishida H
J Anus Rectum Colon; 2020; 4(1):34-40. PubMed ID: 32002474
[TBL] [Abstract][Full Text] [Related]
30. FDG-PET reflects tumor viability on SUV in colorectal cancer liver metastasis.
Watanabe A; Harimoto N; Yokobori T; Araki K; Kubo N; Igarashi T; Tsukagoshi M; Ishii N; Yamanaka T; Handa T; Oyama T; Higuchi T; Shirabe K
Int J Clin Oncol; 2020 Feb; 25(2):322-329. PubMed ID: 31612350
[TBL] [Abstract][Full Text] [Related]
31. Preoperative PET/CT
Chen R; Wang Y; Zhou X; Huang G; Liu J
Contrast Media Mol Imaging; 2018; 2018():5802109. PubMed ID: 30515068
[TBL] [Abstract][Full Text] [Related]
32. Neoadjuvant (Chemo)radiotherapy With Total Mesorectal Excision Only Is Not Sufficient to Prevent Lateral Local Recurrence in Enlarged Nodes: Results of the Multicenter Lateral Node Study of Patients With Low cT3/4 Rectal Cancer.
Ogura A; Konishi T; Cunningham C; Garcia-Aguilar J; Iversen H; Toda S; Lee IK; Lee HX; Uehara K; Lee P; Putter H; van de Velde CJH; Beets GL; Rutten HJT; Kusters M;
J Clin Oncol; 2019 Jan; 37(1):33-43. PubMed ID: 30403572
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic value of FDG-PET/CT for lateral pelvic lymph node metastasis in rectal cancer treated with preoperative chemoradiotherapy.
Ishihara S; Kawai K; Tanaka T; Kiyomatsu T; Hata K; Nozawa H; Morikawa T; Watanabe T
Tech Coloproctol; 2018 May; 22(5):347-354. PubMed ID: 29623475
[TBL] [Abstract][Full Text] [Related]
34. Mesorectal Excision With or Without Lateral Lymph Node Dissection for Clinical Stage II/III Lower Rectal Cancer (JCOG0212): A Multicenter, Randomized Controlled, Noninferiority Trial.
Fujita S; Mizusawa J; Kanemitsu Y; Ito M; Kinugasa Y; Komori K; Ohue M; Ota M; Akazai Y; Shiozawa M; Yamaguchi T; Bandou H; Katsumata K; Murata K; Akagi Y; Takiguchi N; Saida Y; Nakamura K; Fukuda H; Akasu T; Moriya Y;
Ann Surg; 2017 Aug; 266(2):201-207. PubMed ID: 28288057
[TBL] [Abstract][Full Text] [Related]
35. Prediction of Lateral Pelvic Lymph-Node Metastasis in Low Rectal Cancer by Magnetic Resonance Imaging.
Ishibe A; Ota M; Watanabe J; Suwa Y; Suzuki S; Kanazawa A; Watanabe K; Ichikawa Y; Kunisaki C; Endo I
World J Surg; 2016 Apr; 40(4):995-1001. PubMed ID: 26541864
[TBL] [Abstract][Full Text] [Related]
36. Preoperative evaluation of venous anatomy in laparoscopic complete mesocolic excision for right colon cancer.
Ogino T; Takemasa I; Horitsugi G; Furuyashiki M; Ohta K; Uemura M; Nishimura J; Hata T; Mizushima T; Yamamoto H; Doki Y; Mori M
Ann Surg Oncol; 2014 Jun; 21 Suppl 3():S429-35. PubMed ID: 24633663
[TBL] [Abstract][Full Text] [Related]
37. Postoperative morbidity and mortality after mesorectal excision with and without lateral lymph node dissection for clinical stage II or stage III lower rectal cancer (JCOG0212): results from a multicentre, randomised controlled, non-inferiority trial.
Fujita S; Akasu T; Mizusawa J; Saito N; Kinugasa Y; Kanemitsu Y; Ohue M; Fujii S; Shiozawa M; Yamaguchi T; Moriya Y;
Lancet Oncol; 2012 Jun; 13(6):616-21. PubMed ID: 22591948
[TBL] [Abstract][Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
